Stock Events

Stock Events

Candel Therapeutics (CADL) Q3 2025 Earnings

14AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

-0.4

-0.22

-0.05

0.13

Details

Expected EPS

-0.1637

Actual EPS

-0.09

Surprise EPS

0.07

Surprise Percent

+45.02%

Description

Candel Therapeutics (CADL) has reported earnings of -0.09 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.